|
SPTLC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.86060003146838E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66890000047526E-07 |
| Normal-vs-Stage2 |
1.402260E-02 |
| Normal-vs-Stage3 |
2.074200E-01 |
| Normal-vs-Stage4 |
3.485200E-01 |
| Stage1-vs-Stage2 |
4.819600E-01 |
| Stage1-vs-Stage3 |
1.149780E-01 |
| Stage1-vs-Stage4 |
1.642380E-02 |
| Stage2-vs-Stage3 |
8.382500E-02 |
| Stage2-vs-Stage4 |
5.088100E-02 |
| Stage3-vs-Stage4 |
6.475400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.02709998681416E-09 |
| Normal-vs-AfricanAmerican |
4.801600E-03 |
| Normal-vs-Asian |
9.126800E-01 |
| Caucasian-vs-AfricanAmerican |
3.667600E-01 |
| Caucasian-vs-Asian |
2.122600E-01 |
| AfricanAmerican-vs-Asian |
3.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.98370000320725E-08 |
| Normal-vs-Female |
3.64330000000024E-05 |
| Male-vs-Female |
1.493960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.726200E-02 |
| Normal-vs-Extreme_Weight |
5.352500E-04 |
| Normal-vs-Obese |
1.73448999999382E-05 |
| Normal-vs-Extreme_Obese |
2.234200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.758800E-01 |
| Normal_Weight-vs-Obese |
1.326360E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.341000E-01 |
| Extreme_Weight-vs-Obese |
9.157900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.463600E-01 |
| Obese-vs-Extreme_Obese |
9.178600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.160100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.80669999966443E-08 |
| Normal-vs-Age(61-80Yrs) |
3.59979999997595E-06 |
| Normal-vs-Age(81-100Yrs) |
2.367000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.824600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.837800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.508400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.284200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.258100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.532780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.99769994885446E-10 |
| Normal-VS-Type2 PRCC |
2.643700E-02 |
| Normal-VS-KIRP CIMP |
1.296590E-01 |
| Normal-VS-Unclassified PRCC |
5.800000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.541500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.830400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.547000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.049200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.906250E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.657200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.037600E-02 |
| Normal-vs-N1 |
4.632400E-02 |
| Normal-vs-N2 |
1.274750E-01 |
| N0-vs-N1 |
7.113600E-01 |
| N0-vs-N2 |
1.921760E-01 |
| N1-vs-N2 |
1.410970E-01 |
|
|
